Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PDSB

PDS Biotechnology (PDSB)

PDS Biotechnology Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PDSB
DateTimeSourceHeadlineSymbolCompany
16/05/202407:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PDSBPDS Biotechnology Corporation
15/05/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PDSBPDS Biotechnology Corporation
09/05/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PDSBPDS Biotechnology Corporation
24/01/202408:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PDSBPDS Biotechnology Corporation
24/01/202408:31Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PDSBPDS Biotechnology Corporation
23/01/202409:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PDSBPDS Biotechnology Corporation
23/01/202408:45GlobeNewswire Inc.PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical OfficerNASDAQ:PDSBPDS Biotechnology Corporation
17/01/202400:00GlobeNewswire Inc.PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology ConferenceNASDAQ:PDSBPDS Biotechnology Corporation
05/12/202308:50GlobeNewswire Inc.PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PDSBPDS Biotechnology Corporation
05/12/202308:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PDSBPDS Biotechnology Corporation
28/11/202323:30GlobeNewswire Inc.PDS Biotech Appoints Lars Boesgaard as Chief Financial OfficerNASDAQ:PDSBPDS Biotechnology Corporation
28/11/202322:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PDSBPDS Biotechnology Corporation
14/11/202323:30GlobeNewswire Inc.PDS Biotech Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:PDSBPDS Biotechnology Corporation
10/11/202308:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PDSBPDS Biotechnology Corporation
10/11/202300:00GlobeNewswire Inc.PDS Biotech Announces Updated Survival Data from NCI-Led Phase 2 Clinical Trial of PDS0101-Based Triple Combination Therapy in Advanced HPV16-Positive Cancer Patients which Show 75% Survival of ICI Naïve Patients at 36 MonthsNASDAQ:PDSBPDS Biotechnology Corporation
08/11/202300:00GlobeNewswire Inc.PDS Biotechnology Announces Conference Call and Webcast for Third Quarter 2023 Financial ResultsNASDAQ:PDSBPDS Biotechnology Corporation
24/10/202307:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PDSBPDS Biotechnology Corporation
23/10/202323:00GlobeNewswire Inc.PDS Biotech Announces Preliminary Biomarker Study Results in Subset of Advanced HPV-Positive Head and Neck Cancer Patients at ESMONASDAQ:PDSBPDS Biotechnology Corporation
12/10/202307:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PDSBPDS Biotechnology Corporation
11/10/202323:00GlobeNewswire Inc.PDS Biotech Announces Interim Safety and Immune Response Data from Phase 1/2 Clinical Trial Evaluating Novel Antibody Drug Conjugate PDS0301 Combined with Docetaxel to Treat Metastatic Prostate CancerNASDAQ:PDSBPDS Biotechnology Corporation
04/10/202307:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PDSBPDS Biotechnology Corporation
04/10/202307:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PDSBPDS Biotechnology Corporation
04/10/202300:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PDSBPDS Biotechnology Corporation
03/10/202322:00GlobeNewswire Inc.PDS Biotech Announces Interim 24-Month Survival Rate of 74% in Immune Checkpoint Inhibitor Naïve Head and Neck Cancer Patients Treated with PDS0101 in Combination with KEYTRUDA® (pembrolizumab)NASDAQ:PDSBPDS Biotechnology Corporation
03/10/202307:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PDSBPDS Biotechnology Corporation
02/10/202323:00GlobeNewswire Inc.PDS Biotech Announces PDS0101 Combined with Chemoradiotherapy Associated with Rapid Decline in Circulating Tumor DNA (ctDNA/cfDNA)NASDAQ:PDSBPDS Biotechnology Corporation
26/09/202322:00GlobeNewswire Inc.PDS Biotech to Present at the LD Micro Main Event XVINASDAQ:PDSBPDS Biotechnology Corporation
25/09/202322:00GlobeNewswire Inc.PDS Biotech Reschedules Key Opinion Leader Roundtable Addressing Current and Future Treatments for Recurrent/Metastatic HPV-Positive HNSCC and the Potential Application of PDS0101NASDAQ:PDSBPDS Biotechnology Corporation
21/09/202306:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PDSBPDS Biotechnology Corporation
21/09/202306:05GlobeNewswire Inc.PDS Biotech to Participate in the 2023 Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:PDSBPDS Biotechnology Corporation
 Showing the most relevant articles for your search:NASDAQ:PDSB